HEADER GENE REGULATION 19-NOV-19 6V0Q TITLE CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BRD7 BOUND TO TG003 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 7; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: 75 KDA BROMODOMAIN PROTEIN,PROTEIN CELTIX-1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD7, BP75, CELTIX1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VARIANT: RIPL; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS BRD7, BAF, PBAF, MSWI/SNF, GENE REGULATION, TG003 EXPDTA X-RAY DIFFRACTION AUTHOR M.R.KARIM,A.CHAN,E.SCHONBRUNN REVDAT 3 11-OCT-23 6V0Q 1 REMARK REVDAT 2 08-APR-20 6V0Q 1 JRNL REVDAT 1 11-MAR-20 6V0Q 0 JRNL AUTH R.M.KARIM,A.CHAN,J.Y.ZHU,E.SCHONBRUNN JRNL TITL STRUCTURAL BASIS OF INHIBITOR SELECTIVITY IN THE BRD7/9 JRNL TITL 2 SUBFAMILY OF BROMODOMAINS. JRNL REF J.MED.CHEM. V. 63 3227 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32091206 JRNL DOI 10.1021/ACS.JMEDCHEM.9B01980 REMARK 2 REMARK 2 RESOLUTION. 1.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.68 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 56781 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1192 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.6800 - 3.5100 0.97 6299 135 0.1627 0.1830 REMARK 3 2 3.5100 - 2.7900 0.98 6222 133 0.1800 0.1848 REMARK 3 3 2.7900 - 2.4400 0.99 6202 133 0.1869 0.2367 REMARK 3 4 2.4400 - 2.2100 0.99 6215 134 0.1786 0.2456 REMARK 3 5 2.2100 - 2.0600 0.97 6042 129 0.1816 0.2115 REMARK 3 6 2.0600 - 1.9300 0.98 6096 131 0.2052 0.2614 REMARK 3 7 1.9300 - 1.8400 0.99 6183 133 0.2108 0.3062 REMARK 3 8 1.8400 - 1.7600 0.99 6143 131 0.2069 0.2701 REMARK 3 9 1.7600 - 1.6900 0.99 6187 133 0.2064 0.2586 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.168 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.343 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4105 REMARK 3 ANGLE : 0.849 5518 REMARK 3 CHIRALITY : 0.047 584 REMARK 3 PLANARITY : 0.005 699 REMARK 3 DIHEDRAL : 21.378 1647 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6V0Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-NOV-19. REMARK 100 THE DEPOSITION ID IS D_1000245559. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-APR-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI FILTER REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE 20180409 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56788 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.690 REMARK 200 RESOLUTION RANGE LOW (A) : 37.680 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 6.728 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.7700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.69 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.73 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 6.95 REMARK 200 R MERGE FOR SHELL (I) : 0.29700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.790 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6PPA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M (NH4)2SO4, 0.05 M BIS-TRIS (PH REMARK 280 6.5), AND 30 % PENTAERYTHRITOL ETHOXYLATE, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 18.39000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -36.78000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 128 REMARK 465 SER A 129 REMARK 465 GLU A 130 REMARK 465 VAL A 131 REMARK 465 GLU B 128 REMARK 465 SER B 129 REMARK 465 GLU B 130 REMARK 465 VAL B 131 REMARK 465 ASP B 249 REMARK 465 LEU B 250 REMARK 465 GLU C 128 REMARK 465 SER C 129 REMARK 465 GLU C 130 REMARK 465 VAL C 131 REMARK 465 ASP C 249 REMARK 465 LEU C 250 REMARK 465 GLU D 128 REMARK 465 SER D 129 REMARK 465 GLU D 130 REMARK 465 VAL D 131 REMARK 465 ASP D 249 REMARK 465 LEU D 250 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 151 63.96 -119.58 REMARK 500 ASP D 151 68.22 -119.60 REMARK 500 LEU D 232 36.81 -92.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 542 DISTANCE = 6.24 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EAE A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EAE B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EAE C 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO D 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EAE D 302 DBREF 6V0Q A 130 250 UNP Q9NPI1 BRD7_HUMAN 130 250 DBREF 6V0Q B 130 250 UNP Q9NPI1 BRD7_HUMAN 130 250 DBREF 6V0Q C 130 250 UNP Q9NPI1 BRD7_HUMAN 130 250 DBREF 6V0Q D 130 250 UNP Q9NPI1 BRD7_HUMAN 130 250 SEQADV 6V0Q GLU A 128 UNP Q9NPI1 EXPRESSION TAG SEQADV 6V0Q SER A 129 UNP Q9NPI1 EXPRESSION TAG SEQADV 6V0Q GLU B 128 UNP Q9NPI1 EXPRESSION TAG SEQADV 6V0Q SER B 129 UNP Q9NPI1 EXPRESSION TAG SEQADV 6V0Q GLU C 128 UNP Q9NPI1 EXPRESSION TAG SEQADV 6V0Q SER C 129 UNP Q9NPI1 EXPRESSION TAG SEQADV 6V0Q GLU D 128 UNP Q9NPI1 EXPRESSION TAG SEQADV 6V0Q SER D 129 UNP Q9NPI1 EXPRESSION TAG SEQRES 1 A 123 GLU SER GLU VAL GLU GLN THR PRO LEU GLN GLU ALA LEU SEQRES 2 A 123 ASN GLN LEU MET ARG GLN LEU GLN ARG LYS ASP PRO SER SEQRES 3 A 123 ALA PHE PHE SER PHE PRO VAL THR ASP PHE ILE ALA PRO SEQRES 4 A 123 GLY TYR SER MET ILE ILE LYS HIS PRO MET ASP PHE SER SEQRES 5 A 123 THR MET LYS GLU LYS ILE LYS ASN ASN ASP TYR GLN SER SEQRES 6 A 123 ILE GLU GLU LEU LYS ASP ASN PHE LYS LEU MET CYS THR SEQRES 7 A 123 ASN ALA MET ILE TYR ASN LYS PRO GLU THR ILE TYR TYR SEQRES 8 A 123 LYS ALA ALA LYS LYS LEU LEU HIS SER GLY MET LYS ILE SEQRES 9 A 123 LEU SER GLN GLU ARG ILE GLN SER LEU LYS GLN SER ILE SEQRES 10 A 123 ASP PHE MET ALA ASP LEU SEQRES 1 B 123 GLU SER GLU VAL GLU GLN THR PRO LEU GLN GLU ALA LEU SEQRES 2 B 123 ASN GLN LEU MET ARG GLN LEU GLN ARG LYS ASP PRO SER SEQRES 3 B 123 ALA PHE PHE SER PHE PRO VAL THR ASP PHE ILE ALA PRO SEQRES 4 B 123 GLY TYR SER MET ILE ILE LYS HIS PRO MET ASP PHE SER SEQRES 5 B 123 THR MET LYS GLU LYS ILE LYS ASN ASN ASP TYR GLN SER SEQRES 6 B 123 ILE GLU GLU LEU LYS ASP ASN PHE LYS LEU MET CYS THR SEQRES 7 B 123 ASN ALA MET ILE TYR ASN LYS PRO GLU THR ILE TYR TYR SEQRES 8 B 123 LYS ALA ALA LYS LYS LEU LEU HIS SER GLY MET LYS ILE SEQRES 9 B 123 LEU SER GLN GLU ARG ILE GLN SER LEU LYS GLN SER ILE SEQRES 10 B 123 ASP PHE MET ALA ASP LEU SEQRES 1 C 123 GLU SER GLU VAL GLU GLN THR PRO LEU GLN GLU ALA LEU SEQRES 2 C 123 ASN GLN LEU MET ARG GLN LEU GLN ARG LYS ASP PRO SER SEQRES 3 C 123 ALA PHE PHE SER PHE PRO VAL THR ASP PHE ILE ALA PRO SEQRES 4 C 123 GLY TYR SER MET ILE ILE LYS HIS PRO MET ASP PHE SER SEQRES 5 C 123 THR MET LYS GLU LYS ILE LYS ASN ASN ASP TYR GLN SER SEQRES 6 C 123 ILE GLU GLU LEU LYS ASP ASN PHE LYS LEU MET CYS THR SEQRES 7 C 123 ASN ALA MET ILE TYR ASN LYS PRO GLU THR ILE TYR TYR SEQRES 8 C 123 LYS ALA ALA LYS LYS LEU LEU HIS SER GLY MET LYS ILE SEQRES 9 C 123 LEU SER GLN GLU ARG ILE GLN SER LEU LYS GLN SER ILE SEQRES 10 C 123 ASP PHE MET ALA ASP LEU SEQRES 1 D 123 GLU SER GLU VAL GLU GLN THR PRO LEU GLN GLU ALA LEU SEQRES 2 D 123 ASN GLN LEU MET ARG GLN LEU GLN ARG LYS ASP PRO SER SEQRES 3 D 123 ALA PHE PHE SER PHE PRO VAL THR ASP PHE ILE ALA PRO SEQRES 4 D 123 GLY TYR SER MET ILE ILE LYS HIS PRO MET ASP PHE SER SEQRES 5 D 123 THR MET LYS GLU LYS ILE LYS ASN ASN ASP TYR GLN SER SEQRES 6 D 123 ILE GLU GLU LEU LYS ASP ASN PHE LYS LEU MET CYS THR SEQRES 7 D 123 ASN ALA MET ILE TYR ASN LYS PRO GLU THR ILE TYR TYR SEQRES 8 D 123 LYS ALA ALA LYS LYS LEU LEU HIS SER GLY MET LYS ILE SEQRES 9 D 123 LEU SER GLN GLU ARG ILE GLN SER LEU LYS GLN SER ILE SEQRES 10 D 123 ASP PHE MET ALA ASP LEU HET EDO A 301 4 HET EDO A 302 4 HET PO4 A 303 5 HET CL A 304 1 HET EAE A 305 17 HET GOL A 306 6 HET EAE B 301 17 HET EDO C 301 4 HET EAE C 302 17 HET EDO D 301 4 HET EAE D 302 17 HETNAM EDO 1,2-ETHANEDIOL HETNAM PO4 PHOSPHATE ION HETNAM CL CHLORIDE ION HETNAM EAE (1~{Z})-1-(3-ETHYL-5-METHOXY-1,3-BENZOTHIAZOL-2- HETNAM 2 EAE YLIDENE)PROPAN-2-ONE HETNAM GOL GLYCEROL HETSYN EDO ETHYLENE GLYCOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 5 EDO 4(C2 H6 O2) FORMUL 7 PO4 O4 P 3- FORMUL 8 CL CL 1- FORMUL 9 EAE 4(C13 H15 N O2 S) FORMUL 10 GOL C3 H8 O3 FORMUL 16 HOH *487(H2 O) HELIX 1 AA1 THR A 134 LYS A 150 1 17 HELIX 2 AA2 GLY A 167 ILE A 172 1 6 HELIX 3 AA3 ASP A 177 ASN A 187 1 11 HELIX 4 AA4 SER A 192 ASN A 211 1 20 HELIX 5 AA5 THR A 215 LEU A 232 1 18 HELIX 6 AA6 SER A 233 MET A 247 1 15 HELIX 7 AA7 THR B 134 LYS B 150 1 17 HELIX 8 AA8 GLY B 167 ILE B 172 1 6 HELIX 9 AA9 ASP B 177 ASN B 187 1 11 HELIX 10 AB1 SER B 192 ASN B 211 1 20 HELIX 11 AB2 THR B 215 LEU B 232 1 18 HELIX 12 AB3 SER B 233 ALA B 248 1 16 HELIX 13 AB4 THR C 134 LYS C 150 1 17 HELIX 14 AB5 ASP C 177 ASN C 187 1 11 HELIX 15 AB6 SER C 192 ASN C 211 1 20 HELIX 16 AB7 THR C 215 LEU C 232 1 18 HELIX 17 AB8 SER C 233 MET C 247 1 15 HELIX 18 AB9 THR D 134 LYS D 150 1 17 HELIX 19 AC1 GLY D 167 ILE D 171 5 5 HELIX 20 AC2 ASP D 177 ASN D 187 1 11 HELIX 21 AC3 SER D 192 ASN D 211 1 20 HELIX 22 AC4 THR D 215 LEU D 232 1 18 HELIX 23 AC5 SER D 233 ALA D 248 1 16 SITE 1 AC1 2 PHE A 163 HOH A 431 SITE 1 AC2 6 THR A 215 ILE A 216 TYR A 217 HOH A 403 SITE 2 AC2 6 HOH A 430 HOH A 497 SITE 1 AC3 5 LYS A 201 HOH A 401 LYS C 150 SER C 227 SITE 2 AC3 5 LYS C 230 SITE 1 AC4 1 GLN A 234 SITE 1 AC5 7 PHE A 155 PHE A 156 ILE A 164 ASN A 211 SITE 2 AC5 7 TYR A 217 HOH A 419 PHE B 163 SITE 1 AC6 4 LYS A 150 LYS C 197 LYS C 201 GLN C 234 SITE 1 AC7 8 PHE A 163 PHE B 155 PHE B 156 VAL B 160 SITE 2 AC7 8 ILE B 164 ASN B 211 TYR B 217 HOH B 416 SITE 1 AC8 4 HIS A 226 LYS A 230 HOH A 411 HOH C 436 SITE 1 AC9 7 PHE C 155 PHE C 156 ILE C 164 ASN C 211 SITE 2 AC9 7 TYR C 217 HOH C 407 PHE D 163 SITE 1 AD1 4 LYS D 184 ASP D 189 GLU D 195 HOH D 422 SITE 1 AD2 6 PHE D 155 PHE D 156 ILE D 164 ASN D 211 SITE 2 AD2 6 TYR D 217 HOH D 401 CRYST1 59.970 36.780 118.960 90.00 101.77 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016675 0.000000 0.003474 0.00000 SCALE2 0.000000 0.027189 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008587 0.00000